Management of QT Interval Elevations in Normal Children
The management of QT interval elevations in normal children requires careful monitoring, discontinuation of QT-prolonging medications, and correction of electrolyte abnormalities to prevent potentially life-threatening arrhythmias.
Assessment and Monitoring
- QT interval should be measured from the onset of the QRS complex to the end of the T wave, using the same electrocardiographic lead consistently for the same patient 1
- For accurate measurement, select the lead with the longest T wave and avoid leads with U waves 1
- When notched or biphasic T waves are present, the end of the entire T wave complex should be considered the end of the QT interval 1
- QT interval must be corrected for heart rate (QTc) using appropriate formulas:
Risk Stratification
- QTc >500 ms is considered high risk for developing significant arrhythmias including Torsades de Pointes 1
- Normal upper limits for QTc in children:
- QTc values between 440-470 ms are considered a "grey zone" due to overlap between affected and unaffected individuals 1
Immediate Management of QT Prolongation
- If QTc reaches >500 ms or increases by >60 ms from baseline, discontinue the causative drug immediately 1
- Continue QTc monitoring until the drug washes out and QTc is documented to be decreasing 1
- For patients receiving QT-prolonging medications, document QTc (including rhythm strip) at baseline and then at least every 8-12 hours 1
- More frequent measurements may be needed if QTc prolongation occurs during drug administration 1
Specific Interventions
- Avoid or discontinue QT-prolonging medications whenever possible 1
- Common QT-prolonging medications in pediatrics include:
- Antipsychotics (haloperidol, thioridazine)
- Antiemetics (ondansetron, dolasetron)
- Macrolide antibiotics (azithromycin, erythromycin)
- Fluoroquinolones (ciprofloxacin, levofloxacin)
- Antihistamines (hydroxyzine) 1
- Common QT-prolonging medications in pediatrics include:
- Monitor and maintain normal electrolyte balance:
- If multiple QT-prolonging drugs must be used, consider substituting with alternatives that have less effect on QT interval (e.g., levofloxacin instead of moxifloxacin) 1
- For children with fever and QT prolongation, reduce fever with antipyretics 1
Ongoing Management
- Document QTc before and after increases in dose of QT-prolonging medications 1
- Consider exercise testing for school-aged children to evaluate QT response to exercise and monitor adequacy of therapy 1
- For children requiring antipsychotics:
Emergency Management of Torsades de Pointes
- External defibrillation is the therapy of choice for hemodynamically unstable patients with Torsades de Pointes 2
- For hemodynamically stable patients with Torsades de Pointes:
Special Considerations
- Children with congenital long QT syndrome require different management approaches, including beta-blockers and possible ICD placement 1
- Children taking stimulant medications for ADHD may have increased risk of cardiac events when they have underlying QT prolongation 1
- QT prolongation risk increases with certain combinations of medications due to drug interactions or metabolism disturbances 1, 2
Prevention Strategies
- Maintain updated lists of medications that prolong QT interval (www.crediblemeds.org) 1, 2
- Perform risk assessment before initiating treatment with QT-prolonging medications 1
- Consider genetic counseling and testing for children with unexplained QT prolongation to rule out congenital long QT syndrome 1